JERSEY, Channel Islands, July 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that the Company has been added to the Russell 2000® and 3000® Indexes
The Honeyman Group, a longstanding Quotient partner, today announced the launch of a new, highly sensitive antibody test utilizing the high-throughput MosaiQ™ platform which coupled with PCR screening can provide a systematic approach for businesses managing teams back-to-work”.
On the 8th of June, reporter Gordon Chree from STV visited Quotient's Allan-Robb Campus in Penicuik, Scotland to interview Quotient Chief Operating Officer. While on site, he was also tested using the MosaiQ COVID-19 Antibody Microarray.
On the 6th of June 2020, The Sun journalist Alex Bellotti visited an hVIVO laboratory in East London to try out the newly launched “gold standard” coronavirus antibody test provided by Quotient using their MosaiQ technology.